References
- 1. van der Linde D, Konings EE, Slager MA, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;58(21):2241-7.10.1016/j.jacc.2011.08.02522078432
- 2. Ishikawa T, Iwashima S, Ohishi A, Nakagawa Y, Ohzeki T. Prevalence of congenital heart disease assessed by echocardiography in 2067 consecutive newborns. Acta Paediatr. 2011;100(8):e55-60.10.1111/j.1651-2227.2011.02248.x21362039
- 3. Kelly RG. The second heart field. Curr Top Dev Biol. 2012;100:33-65.10.1016/B978-0-12-387786-4.00002-622449840
- 4. Spicer DE, Hsu HH, Co-Vu J, Anderson RH, Fricker FJ. Ventricular septal defect. Orphanet J Rare Dis. 2014;9:144.10.1186/s13023-014-0144-2431665825523232
- 5. Corno A. Atrioventricular septal defect. Congenital Heart Defects. Springer-Verlag Berlin Heidelberg 2003;25–32.10.1007/978-3-642-57358-3_5
- 6. Edwards JJ, Gelb BD. Genetics of congenital heart disease. Curr Opin Cardiol. 2016;31(3):235–241.10.1097/HCO.0000000000000274486850426872209
- 7. Cowan JR, Ware SM. Genetics and genetic testing in congenital heart disease. Clin Perinatol. 2015;42(2):373-93.10.1016/j.clp.2015.02.00926042910
- 8. Jin SC, Homsy J, Zaidi S, et al. Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands. Nat Genet. 2017;49(11):1593-1601.10.1038/ng.3970567500028991257
- 9. An Y, Duan W, Huang G, et al. Genome-wide copy number variant analysis for congenital ventricular septal defects in Chinese Han population. BMC Med Genomics. 2016;9:2.10.1186/s12920-015-0163-4470561626742958
- 10. Du L, Xie HN, Li LJ, Zhu YX, Lin MF, Zheng J. [Association between fetal ventricular septal defects and chromosomal abnormalities].Zhonghua Fu Chan Ke Za Zhi. 2013;48(11):805-9.
- 11. Zhang W, Li X, Shen A, Jiao W, Guan X, Li Z. GATA4 mutations in 486 Chinese patients with congenital heart disease. Eur J Med Genet. 2008;51(6):527-35.10.1016/j.ejmg.2008.06.00518672102
- 12. Jacobs JP, O’Brien SM, Pasquali SK, et al. Variation in outcomes for benchmark operations: an analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database. Ann Thorac Surg. 2011;92(6):2184-91.10.1016/j.athoracsur.2011.06.008326375522115229
- 13. Mirzaei M, Mirzaei S, Sepahvand E, Rahmanian Koshkaki A, Kargar Jahromi M. Evaluation of Complications of Heart Surgery in Children With Congenital Heart Disease at Dena Hospital of Shiraz. Glob J Health Sci. 2015 Aug 23;8(5):33-8.10.5539/gjhs.v8n5p33487722626652092
- 14. Russell MW, Chung WK, Kaltman JR, Miller TA. Advances in the Understanding of the Genetic Determinants of Congenital Heart Disease and Their Impact on Clinical Outcomes. J Am Heart Assoc. 2018;7(6): e006906.10.1161/JAHA.117.006906590753729523523
- 15. Dobreanu M, Oprea OR. Laboratory medicine in the era of precision medicine – dream or reality?. Rev Romana Med Lab. 2019;27(2):115-24.10.2478/rrlm-2019-0025
- 16. Lazăr A, Georgescu AM, Vitin A, Azamfirei L. Precision Medicine and its Role in the Treatment of Sepsis: A Personalised View. J Crit Care Med (Targu Mures). 2019;5(3):90-96.10.2478/jccm-2019-0017669807431431921
- 17. Marin TM, Keith K, Davies B, et al. Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation. J Clin Invest. 2011;121(3):1026-43.10.1172/JCI44972304937721339643
- 18. Crauciuc A, Tripon F, Gheorghiu A, Nemes G, Boglis A, Banescu C. Development, Applications, Benefits, Challenges and Limitations of the New Genome Engineering Technique. An Update Study. Acta Medica Marisiensis. 2017;63(1):4-9.10.1515/amma-2017-0007
- 19. Richards RM, Sotillo E, Majzner RG. CAR T Cell Therapy for Neuroblastoma. Front Immunol. 2018;9:2380.10.3389/fimmu.2018.02380623277830459759
- 20. Ye F, Setozaki S, Kowalski J, et al. Progress in the Generation of Multiple Lineage Human-iPSC-Derived 3D-Engineered Cardiac Tissues for Cardiac Repair. In: Nakanishi T., Baldwin H., Fineman J., Yamagishi H. (eds) Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension. Springer, Singapore. 2020:353-361.10.1007/978-981-15-1185-1_54
- 21. Jacinto FV, Link W, Ferreira BI. CRISPR/Cas9-mediated Genome Editing: From Basic Research to Translational Medicine. J Cell Mol Med. 2020;24(7):3766-3778.10.1111/jcmm.14916717140232096600
- 22. Tripon F, Crauciuc GA, Moldovan VG, Bogliș A, Benedek IJ, Lázár E, et al. Simultaneous FLT3, NPM1 and DNMT3A mutations in adult patients with acute myeloid leukemia – case study. Rev Romana Med Lab. 2019;27(3):245-54.10.2478/rrlm-2019-0022
- 23. Pierpont ME, Brueckner M, Chung WK, et al. Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association. Circulation. 2018;138(21):e653-e711.10.1161/CIR.0000000000000606655576930571578
- 24. Maslen CL, Babcock D, Robinson SW, et al. CRELD1 mutations contribute to the occurrence of cardiac atrioventricular septal defects in Down syndrome. Am J Med Genet A. 2006;140(22):2501-5.10.1002/ajmg.a.3149417036335
- 25. Levy M, Eyries M, Szezepanski I, et al. Genetic analyses in a cohort of children with pulmonary hypertension. Eur Respir J. 2016;48(4):1118-1126.10.1183/13993003.00211-201627587546
- 26. Courtens W, Wauters J, Wojciechowski M, et al. A de novo subtelomeric monosomy 11q (11q24.2-qter) and trisomy 20q (20q13.3-qter) in a girl with findings compatible with Jacobsen syndrome: case report and review. Clin Dysmorphol. 2007;16(4):231-9.10.1097/MCD.0b013e328274230317786114
- 27. Favier R, Akshoomoff N, Mattson S, Grossfeld P. Jacobsen syndrome: Advances in our knowledge of phenotype and genotype. Am J Med Genet C Semin Med Genet. 2015;169(3):239-50.10.1002/ajmg.c.3144826285164
- 28. Bunduki V, Zugaib M. Atlas of Fetal Ultrasound. Fetal Aneuploidies. Springer, Cham 2017;211-235.10.1007/978-3-319-54798-5_17
- 29. Cai M, Huang H, Su L, et al. Chromosomal abnormalities and copy number variations in fetal ventricular septal defects.Mol Cytogenet. 2018;11:58.10.1186/s13039-018-0408-y626405230519285
- 30. Carey AS, Liang L, Edwards J, et al. Effect of copy number variants on outcomes for infants with single ventricle heart defects. Circ Cardiovasc Genet. 2013;6(5):444-51.10.1161/CIRCGENETICS.113.000189398796624021551
- 31. Russell MW, Chung WK, Kaltman JR, Miller TA. Advances in the Understanding of the Genetic Determinants of Congenital Heart Disease and Their Impact on Clinical Outcomes. J Am Heart Assoc. 2018;7(6). pii: e006906.10.1161/JAHA.117.006906590753729523523
- 32. Jordan VK, Zaveri HP, Scott DA. 1p36 deletion syndrome: an update. Appl Clin Genet. 2015;8:189–200.
- 33. Pierpont ME, Basson CT, Benson DW Jr. et al. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation. 2007;115(23):3015-38.10.1161/CIRCULATIONAHA.106.18305617519398
- 34. McElhinney DB, Driscoll DA, Levin ER, Jawad AF, Emanuel BS, Goldmuntz E. Chromosome 22q11 deletion in patients with ventricular septal defect: frequency and associated cardiovascular anomalies. Pediatrics. 2003;112(6 Pt 1):e472.10.1542/peds.112.6.e47214654648
- 35. Deshpande A, Weiss LA. Recurrent reciprocal copy number variants: Roles and rules in neurodevelopmental disorders. Dev Neurobiol. 2018;78(5):519-530.10.1002/dneu.2258729575775
- 36. Costain G, Silversides CK, Bassett AS. The importance of copy number variation in congenital heart disease. NPJ Genom Med. 2016;1:16031.10.1038/npjgenmed.2016.31550572828706735
- 37. Bernier R, Steinman KJ, Reilly B, et al. Clinical phenotype of the recurrent 1q21.1 copy-number variant. Genet Med. 2016;18(4):341-9.10.1038/gim.2015.78726304426066539
- 38. Guida V, Ferese R, Rocchetti M, et al. A variant in the carboxyl-terminus of connexin 40 alters GAP junctions and increases risk for tetralogy of Fallot. Eur J Hum Genet. 2013;21(1):69-75.10.1038/ejhg.2012.109353325822713807
- 39. Saliba A, Figueiredo ACV, Baroneza JE, et al. Genetic and Genomics in Congenital Heart Disease: A Clinical Review. J Pediatr (Rio J). 2019:S0021-7557(19)30443-7.
- 40. Turnpenny PD, Ellard S. Alagille syndrome: pathogenesis, diagnosis and management. Eur J Hum Genet. 2012;20(3): 251–257.10.1038/ejhg.2011.181328317221934706
- 41. Lu F, Morrissette JJ, Spinner NB. Conditional JAG1 Mutation Shows the Developing Heart Is More Sensitive Than Developing Liver to JAG1 Dosage. Am J Hum Genet. 2003;72(4):1065–1070.10.1086/374386118033912649809
- 42. Tsai EA, Gilbert MA, Grochowski CM, et al. THBS2 Is a Candidate Modifier of Liver Disease Severity in Alagille Syndrome.Cell Mol Gastroenterol Hepatol. 2016;2(5):663-675.10.1016/j.jcmgh.2016.05.013504288828090565
- 43. McDermott DA, Bressan MC, He J, et al. TBX5 genetic testing validates strict clinical criteria for Holt-Oram syndrome. Pediatr Res. 2005;58(5):981-6.10.1203/01.PDR.0000182593.95441.6416183809
- 44. Barisic I, Boban L, Greenlees R, et al. Holt Oram syndrome: a registry-based study in Europe. Orphanet J Rare Dis. 2014;9:156.10.1186/s13023-014-0156-y424518325344219
- 45. Nyboe D, Kreiborg S, Darvann T, Dunø M, Nissen KR, Hove HB. A study of familial Char syndrome involving the TFAP2B gene with a focus on facial shape characteristics.Clin Dysmorphol. 2018;27(3):71-77.10.1097/MCD.000000000000022229683802
- 46. Massaad E, Tfayli H, Awwad J, Nabulsi M, Farra C. Char Syndrome a novel mutation and new insights: A clinical report. Eur J Med Genet. 2018. pii: S1769-7212(18)30785-7.
- 47. Nyboe D, Kreiborg S, Darvann T, Dunø M, Nissen KR, Hove HB. A study of familial Char syndrome involving the TFAP2B gene with a focus on facial shape characteristics. Clin Dysmorphol. 2018;27(3):71-77.10.1097/MCD.0000000000000222
- 48. van Ravenswaaij-Arts CMA, Blake K, Martin DM. Support for the Diagnosis of CHARGE Syndrome. JAMA Otolaryngol Head Neck Surg. 2017;143(6):634-635.10.1001/jamaoto.2016.476228241200
- 49. Corsten-Janssen N, van Ravenswaaij-Arts CMA, Kapusta L. Congenital arch vessel anomalies in CHARGE syndrome: A frequent feature with risk for co-morbidity. Int J Cardiol Heart Vasc. 2016;12:21-25.10.1016/j.ijcha.2016.05.015545415328616537
- 50. Corsten-Janssen N, Kerstjens-Frederikse WS, du Marchie Sarvaas GJ, et al. The cardiac phenotype in patients with a CHD7 mutation. Circ Cardiovasc Genet. 2013;6(3):248-54.10.1161/CIRCGENETICS.113.00005423677905
- 51. Digilio MC, Gnazzo M, Lepri F. et al. Congenital heart defects in molecularly proven Kabuki syndrome patients. Am J Med Genet A. 2017;173(11):2912-2922.10.1002/ajmg.a.3841728884922
- 52. Yoon JK, Ahn KJ, Kwon BS, et al. The strong association of left-side heart anomalies with Kabuki syndrome. Korean J Pediatr. 2015;58(7):256-62.10.3345/kjp.2015.58.7.256454318526300940
- 53. Tartaglia M, Cordeddu V, Chang H, et al. Paternal germline origin and sex-ratio distortion in transmission of PTPN11 mutations in Noonan syndrome.Am J Hum Genet. 2004;75(3):492-7.10.1086/423493118202715248152
- 54. Ramond F, Duband S, Croisille P, et al. Expanding the cardiac spectrum of Noonan syndrome with RIT1 variant: Left main coronary artery atresia causing sudden death. Eur J Med Genet. 2017;60(6):299-302.10.1016/j.ejmg.2017.03.00928347726
- 55. Roberts AE, Araki T, Swanson KD, et al. Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat Genet. 2007;39(1):70-4.10.1038/ng192617143285
- 56. Ayerza Casas A, Puisac Uriol B, Teresa Rodrigo ME, Hernández Marcos M, Ramos Fuentes FJ, Pie Juste J. Cornelia De Lange Syndrome: Congenital Heart Disease in 149 Patients. Med Clin (Barc). 2017 Oct 11;149(7):300-302.10.1016/j.medcle.2017.03.024
- 57. Yuan SM. Congenital Heart Defects in Williams Syndrome. Turk J Pediatr. 2017;59(3):225-232.10.24953/turkjped.2017.03.00129376566
- 58. Bardawil T, Khalil S, Bergqvist C, et al. Genetics of Inherited Cardiocutaneous Syndromes: A Review. Open Heart. 2016 Nov 22;3(2):e000442.10.1136/openhrt-2016-000442513340327933191
- 59. Fergelot P, Van Belzen M, Van Gils J, et al. Phenotype and Genotype in 52 Patients With Rubinstein-Taybi Syndrome Caused by EP300 Mutations. Am J Med Genet A. 2016 Dec;170(12):3069-3082.10.1002/ajmg.a.3794027648933
- 60. Barisic I, Boban L, Akhmedzhanova D, et al. Beckwith Wiedemann Syndrome: A Population-Based Study on Prevalence, Prenatal Diagnosis, Associated Anomalies and Survival in Europe. Eur J Med Genet 2018 Sep;61(9):499-507.10.1016/j.ejmg.2018.05.01429753922
- 61. Prosnitz AR, Leopold J, Irons M, Jenkins K, Roberts AE. Pulmonary Vein Stenosis in Patients With Smith-Lemli-Opitz Syndrome. Congenit Heart Dis. 2017 Jul;12(4):475-483.10.1111/chd.12471582518228719049
- 62. Accogli A, Traverso M, Madia F, et al. A Novel Xp22.13 Microdeletion in Nance-Horan Syndrome. Birth Defects Res. 2017 Jul 3;109(11):866-868.10.1002/bdr2.103228464487
- 63. Muntean I, Togănel R, Benedek T. Genetics of Congenital Heart Disease: Past and Present. Biochem Genet. 2017;55(2):105-123.10.1007/s10528-016-9780-727807680
- 64. Pang S, Liu Y, Zhao Z, Huang W, Chen D, Yan B. Novel and functional sequence variants within the TBX2 gene promoter in ventricular septal defects. Biochimie. 2013;95(9):1807-9.10.1016/j.biochi.2013.05.00723727221
- 65. De Bock M, Kerrebrouck M, Wang N, Leybaert L. Neurological manifestations of oculodentodigital dysplasia: a Cx43 channelopathy of the central nervous system? Front Pharmacol. 2013;4:120.
- 66. Izumi K, Lippa AM, Wilkens A, Feret HA, McDonald-McGinn DM, Zackai EH. c Am J Med Genet A. 2013;161A(12):3150-4.10.1002/ajmg.a.3615924115525
- 67. Wang B, Wen Q, Xie X, et al. Mutation analysis of Connexon43 gene in Chinese patients with congenital heart defects. Int J Cardiol. 2010;145(3):487-9.10.1016/j.ijcard.2009.06.02619615768
- 68. Zaidi S, Choi M, Wakimoto H, et al. De novo mutations in histone-modifying genes in congenital heart disease. Nature. 2013;498(7453):220-3.10.1038/nature12141370662923665959
- 69. Huang RT, Wang J, Xue S. et al. TBX20 loss-of-function mutation responsible for familial tetralogy of Fallot or sporadic persistent truncus arteriosus. Int J Med Sci. 2017;14(4):323-332.10.7150/ijms.17834543647428553164
- 70. Yoshida A, Morisaki H, Nakaji M, et al. Genetic mutation analysis in Japanese patients with non-syndromic congenital heart disease. J Hum Genet. 2016;61(2):157-62.10.1038/jhg.2015.12626490186
- 71. Chen J, Qi B, Zhao J, Liu W, Duan R, Zhang M. A novel mutation of GATA4 (K300T) associated with familial atrial septal defect. Gene. 2016;575(2 Pt 2):473-477.10.1016/j.gene.2015.09.02126376067
- 72. Han H, Chen Y, Liu G, Han Z, Zhao Z, Tang Y. GATA4 transgenic mice as an in vivo model of congenital heart disease. Int J Mol Med. 2015;35(6):1545-53.10.3892/ijmm.2015.2178443292525873328
- 73. Kodo K, Nishizawa T, Furutani M, et al. GATA6 mutations cause human cardiac outflow tract defects by disrupting semaphorin-plexin signaling. Proc Natl Acad Sci U S A. 2009;106(33):13933-8.10.1073/pnas.0904744106272899819666519
- 74. Allen HL, Flanagan SE, Shaw-Smith C. et al. GATA6 haploinsufficiency causes pancreatic agenesis in humans. Nat Genet. 2011;44(1):20-22.10.1038/ng.1035406296222158542
- 75. Xu M, Wu X, Li Y, et al. CITED2 mutation and methylation in children with congenital heart disease. J Biomed Sci. 2014;21:7.10.1186/1423-0127-21-7391753524456003
- 76. Behiry EG, Al-Azzouny MA, Sabry D, Behairy OG, Salem NE. Association of NKX2-5, GATA4, and TBX5 Polymorphisms With Congenital Heart Disease in Egyptian Children. Mol Genet Genomic Med. 2019 May;7(5):e612.10.1002/mgg3.612650302630834692
- 77. Bogliș A, Tripon F, Bănescu C. The utility of molecular genetic techniques in craniosynostosis cases associated with intellectual disability. Rev Romana Med Lab. 2018;26(4):471-7.10.2478/rrlm-2018-0033
- 78. Bănescu C. Do we really need genetic tests in current practice?. Rev Romana Med Lab. 2019;27(1):9-14.10.2478/rrlm-2019-0010
- 79. Kelle AM, Qureshi MY, Olson TM, Eidem BW, O’Leary PW. Familial Incidence of Cardiovascular Malformations in Hypoplastic Left Heart Syndrome. Am J Cardiol. 2015;116(11):1762-6.10.1016/j.amjcard.2015.08.04526433269
- 80. Ito S, Chapman KA, Kisling M, John AS. Appropriate Use of Genetic Testing in Congenital Heart Disease Patients. Curr Cardiol Rep. 2017;19(3):24.10.1007/s11886-017-0834-128224467
- 81. Monteiro RAC, de Freitas ML, Vianna GS, et al. Major Contribution of Genomic Copy Number Variation in Syndromic Congenital Heart Disease: The Use of MLPA as the First Genetic Test. Mol Syndromol. 2017;8(5):227-235.10.1159/000477226558252128878606
- 82. Crauciuc GA, Tripon F, Bogliș A, Făgărășan A, Bănescu C. Multiplex ligation dependent probe amplification - A useful, fast and cost-effective method for identification of small supernumerary marker chromosome in children with developmental delay and congenital heart defect. Rev Romana Med Lab. 2018;26(4):461-70.10.2478/rrlm-2018-0032
- 83. Homsy J, Zaidi S, Shen Y, et al. De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies. Science. 2015;350(6265):1262-6.10.1126/science.aac9396489014626785492